RxDoctor Payments Data
★ My doctorsLook up a doctor →

Carlos Pacheco

Endocrinology, Diabetes & Metabolism · Maitland, FLNPI 1104824127

Payments from drug & device makers

$31,985in general payments, 2019–2025

Across 494 payments — averaging $64.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$12K
  • Tandem Diabetes Care, Inc.$6K
  • AbbVie$4K
  • Sanofi-aventis U.S. LLC$2K
  • Lilly USA, LLC$1K
  • Amgen$833
  • plus $6K from 45 others

What the payments were for

  • Speaking & faculty fees$18,23457%
  • Travel & lodging$7592%
  • Food & beverage$12,77240%
  • Education$2191%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novo Nordisk82$12,037
Tandem Diabetes Care, Inc.27$6,111
AbbVie25$3,604
Sanofi-aventis U.S. LLC35$1,865
Lilly USA, LLC50$1,178
Amgen(2 entities)25$833
Bayer15$682
Abbott13$469
BETA Bionics, Inc.8$453
IBSA Pharma Inc.22$410
Radius Health, Inc.16$404
Boehringer Ingelheim24$374
Insulet Corporation7$329
Cequr Corporation3$328
Amneal Pharmaceuticals LLC16$276
Dexcom, Inc.7$212
Johnson & Johnson9$200
Antares Pharma, Inc.11$191
Merck14$177
AstraZeneca(2 entities)10$151
Pfizer6$126
Amarin Pharma, Inc.8$125
Xeris Pharmaceuticals, Inc.5$104
Corcept Therapeutics5$96
Bigfoot Biomedical Inc1$87
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC4$79
Companion Medical, Inc.1$74
Echosens North America, Inc.1$74
Amphastar Pharmaceuticals, Inc.3$70
Rhythm Pharmaceuticals, Inc.2$65
Kowa Pharmaceuticals America, Inc.5$60
Recordati_rare_diseases_inc.1$60
Calliditas Therapeutics US Inc.3$59
Ascendis Pharma Endocrinology Inc2$58
Globus Medical2$58
Neurocrine Biosciences, Inc.2$55
Ipsen Biopharmaceuticals, Inc1$50
Madrigal Pharmaceuticals2$46
Ascensia Diabetes Care US Inc.2$39
Medtronic(2 entities)3$39
Endo Pharmaceuticals Inc.2$36
Mannkind Corporation2$33
Verity Pharmaceuticals Inc.2$33
Valeritas, Inc.2$28
Sequel Med Tech, LLC1$27
Shire North American Group Inc2$23
Vifor Pharma, Inc.1$22
Almatica Pharma LLC1$21
Novartis1$20
Lifescan, Inc.1$16
Renalytix AI, Inc.1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$31,985 in reported general payments places this provider in the 80th percentile of 586 endocrinology, diabetes & metabolism providers in Florida.

See all endocrinology, diabetes & metabolism providers in Florida →

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide114$178,560
JardianceEmpagliflozin104$132,726
TrulicityDulaglutide98$121,602
Tresiba Flextouch U-200Insulin Degludec49$93,856
MounjaroTirzepatide56$91,308
FarxigaDapagliflozin Propanediol45$57,980
SynthroidLevothyroxine Sodium378$38,769
RybelsusSemaglutide14$33,426
JanuviaSitagliptin Phosphate17$22,224
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog31$14,586
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog11$13,783
Janumet XrSitagliptin Phos/Metformin Hcl14$12,267
Lantus SolostarInsulin Glargine,hum.Rec.Anlog56$11,384
VascepaIcosapent Ethyl18$9,729
Novolog FlexpenInsulin Aspart25$9,446

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro, Humalog, Insulin Lispro$1,178$219,193186 claims
Novo NordiskOzempic, Rybelsus, Novolog$12,037$218,368166 claims
Boehringer IngelheimJardiance$374$132,726104 claims
AstraZenecaFarxiga$151$57,98045 claims
AbbVieSynthroid$3,604$38,769378 claims
MerckJanuvia, Janumet Xr$177$34,49131 claims
Amneal Pharmaceuticals LLCUnithroid, Levothyroxine Sodium$276$6,429245 claims
PfizerLevoxyl$126$4,554138 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 586 endocrinology, diabetes & metabolism providers in Florida.

Other endocrinology, diabetes & metabolism in Maitland

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →